A Comprehensive Review on the Phytochemistry, Traditional Uses and Pharmacological Activities of Aegle Marmelos: Current Evidence and Future Perspectives
DOI:
https://doi.org/10.22270/ajprd.v14i5.1869Abstract
Aegle marmelos (L.) Correa (Rutaceae), commonly known as bael, is a medicinally important tree widely distributed across the Indian subcontinent and Southeast Asia. Almost every plant part has been used in Ayurvedic, Siddha and Unani medicine. This review systematically examines the botanical profile, ethnomedicinal uses, phytochemical composition and experimental pharmacological evidence for A. marmelos. Major bioactive classes include alkaloids (aegeline, skimmianine), coumarins (marmelosin, imperatorin, marmin, and marmesin), flavonoids (rutin, quercetin), phenolic acids and terpenoids. Preclinical studies demonstrate antidiabetic, antioxidant, antidiarrhoeal, anti-inflammatory, hepatoprotective, antidepressant, and antihyperlipidaemic, antimicrobial and antifungal activities. Mechanistic insights implicate inhibition of carbohydrate-digesting enzymes, enhancement of endogenous antioxidant defences, modulation of inflammatory pathways and monoaminergic neurotransmission. Despite robust preclinical data, high-quality clinical trials and standardised phytopharmaceutical development remain limited. This review synthesises current evidence, identifies research gaps and outlines future directions for the translational development of A. marmelos-based therapeutics.
Downloads
References
Baliga MS, et al. Aegle marmelos (L.) Correa (Bael) and its phytochemicals in the treatment and prevention of cancer. Integr Cancer Ther 2013;12(3):187–96. https://doi.org/10.1177/1534735412451320.
Khedkar S, Gore P. A review: therapeutic profile of Aegle marmelos (bael). J PharmacognPhytochem 2025;14(2):20–4.
Monika S, Thirumal M, Kumar PR. Phytochemical and biological review of Aegle marmelos Linn. Future Sci OA 2023;9:FSO849. https://doi.org/10.2144/fsoa-2022-0068.
Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos and its relationship with its antioxidant properties. Indian J Physiol Pharmacol 2004;48.
Phuwapraisirisan P, et al. α-Glucosidase inhibitors from Aegle marmelos. Bioorg Med Chem Lett 2008.
Anandharajan R, et al. In vitro glucose uptake activity of Aegle marmelos. J Ethnopharmacol 2006.
Rajan S, et al. Antioxidant and phytochemical properties of Aegle marmelos fruit pulp.
Brijesh S, Daswani P, Tetali P, Antia N, Birdi T. Studies on the antidiarrheal activity of Aegle marmelos unripe fruit: validating its traditional usage. BMC Complement Altern Med 2009;9:47. https://doi.org/10.1186/1472-6882-9-47.
Benni JM, Jayanthi MK, Suresha RN. Evaluation of the anti-inflammatory activity of Aegle marmelos (Bilwa) root. Indian J Pharmacol 2011;43(4):393–7. https://doi.org/10.4103/0253-7613.83108.
Mujeeb M, et al. Free radical scavenging and hepatoprotective activity of Aegle marmelos (Linn.) Corr. leaves against carbon tetrachloride. PharmacieGlobale 2011.
Sharma A, et al. Antidepressive-like effect of Aegle marmelos leaf extract in chronic unpredictable mild stress-induced depression-like behaviour in rats. Biomed Res Int 2022;2022.
Bhuvaneswari R, Sasikumar K. Antihyperlipidemic activity of Aegle marmelos (L.) Corr. leaf extract in Triton WR-1339 induced hyperlipidemic rats. PharmacieGlobale 2013.
Ibrahim NA, et al. Chemical composition, antimicrobial and antifungal activities of essential oils of the leaves of Aegle marmelos (L.) Correa growing in Egypt. J Appl Pharm Sci 2015;5(2):1–5.
Published
How to Cite
Issue
Section
Copyright (c) 2026 Shruti Raval, Dr. Dhaval Patel, Dr. Pankti Dalmati, Payal Prasad, Ritu chandel

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.